Globus Medical Inc. (GMED)
71.87
-0.72 (-0.99%)
At close: Apr 14, 2025, 1:06 PM
-0.99% (1D)
| Bid | 71.74 |
| Market Cap | 11.5B |
| Revenue (ttm) | 2.52B |
| Net Income (ttm) | 102.98M |
| EPS (ttm) | 0.75 |
| PE Ratio (ttm) | 95.83 |
| Forward PE | 26.81 |
| Analyst | Buy |
| Ask | 71.88 |
| Volume | 315,097 |
| Avg. Volume (20D) | 1,351,909 |
| Open | 74.34 |
| Previous Close | 72.59 |
| Day's Range | 71.71 - 74.05 |
| 52-Week Range | 49.33 - 94.93 |
| Beta | 1.29 |
About GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion p...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 3, 2012
Employees 5,300
Stock Exchange NYSE
Ticker Symbol GMED
Website https://www.globusmedical.com
Analyst Forecast
According to 13 analyst ratings, the average rating for GMED stock is "Buy." The 12-month stock price forecast is $97, which is an increase of 34.97% from the latest price.
Stock Forecasts5 months ago
+9.43%
Globus Medical shares are trading higher after the...
Unlock content with
Pro Subscription
5 months ago
+1.15%
Globus Medical shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 guidance above estimates.
